Close menu

March 8th, 2022 | 12:07 CET

Nel, Hensoldt, Perimeter Medical: Hype share or sustainably attractive?

  • medtech
  • Technology
  • defense
  • Hydrogen
Photo credits:

Since Russia's attack on Ukraine, the world has turned upside down. Also, the stock market. The volatility is extreme, as is the uncertainty of many investors. It is worth taking a look at companies in sectors with good long-term prospects. More than ever, these include renewable energies and, as of almost two weeks ago, "unfortunately" also the defense industry. Hydrogen is a key technology, and Nel ASA is a specialist in this field. However, insider sales are causing uncertainty. The same happened at Hensoldt after a major shareholder cashed in - but only for a short time. Medical technology is on the sidelines these days, although companies like Perimeter are working on life-saving technologies.

time to read: 3 minutes | Author: Fabian Lorenz
ISIN: NEL ASA NK-_20 | NO0010081235 , HENSOLDT AG INH O.N. | DE000HAG0005 , PERIMETER MED.IMAG.AI | CA71385D1078

Table of contents:

    Dirk Graszt, CEO, Clean Logistics SE
    "[...] We can convert buses and trucks to be completely climate neutral. In doing so, we take a modular and incremental approach. That means we can work with all current vehicle types and respond to new technology and innovation [...]" Dirk Graszt, CEO, Clean Logistics SE

    Full interview


    Perimeter: To revolutionize cancer surgery

    Before we move on to the industries of the day with renewable energy and armaments, let us first look at a candidate from the future market of medical technology: Perimeter Medical Imaging AI. The Dallas-based US company has a clear goal. They want to revolutionize cancer surgery with ultra-high-resolution, advanced imaging instruments in real-time. With the perimeter technology, surgeons, radiologists and pathologists will in the future be able to visualize microscopic tissue structures at the surgical margins during and after surgery. In order to achieve this goal, an important milestone was reached at the end of February. The US Food and Drug Administration (FDA) granted 510(k) clearance for the commercial launch of the flagship Perimeter S-Series OCT platform. In addition, the clinical trial of the Perimeter B-Series OCT platform in combination with ImgAssist AI in breast lumpectomy has begun. It will involve collecting and analyzing data from approximately 300 patients at eight sites. This study is expected to be completed before the end of the current year.

    The Company plans to roll out its flagship S-Series product at leading hospitals in the coming months and move forward with the B-Series study. To fund this, Perimeter has raised USD 48.7 million. Accordingly, the currently challenging capital market environment will not affect operational development. Instead, it offers an interesting entry opportunity. The share has lost around 50% of its value since its 2021 December high and is currently trading at EUR 1.77. Perimeter is listed on the Toronto Stock Exchange, NASDAQ, and Frankfurt. Its market capitalization is EUR 112 million.

    Nel: Key technology and insider sales

    Already 10 days ago, German Finance Minister Lindner described renewable energies as "freedom energies" and announced massive investments in the sector. The goal, he said, was to reduce dependence on fossil fuels - especially from Russia. Now Lindner has followed up on the weekend. By 2026, the federal government will provide around EUR 200 billion for Germany's climate-friendly transformation. The hydrogen sector, and thus Nel's stock, should benefit from this. Politicians regularly talk about hydrogen as a key technology. But hydrogen is not an energy source but rather an energy storage medium. Since hydrogen only occurs in a bound form, such as in water, it requires energy - such as wind or solar energy - to split it off. Nel insiders, however, do not yet seem convinced of the chances of success. The outgoing Nel CEO Jon André Løkke sold one million Nel shares just over two weeks ago. And last Thursday, a person close to Finn Jebsen, a member of the Nel board of directors, parted with a larger block of shares. Thus, 260,000 Nel shares were sold at an average price of EUR 1.53.

    Hensoldt: KKR cashes in, but prospects are right

    The share of Hensoldt was one of the few winners on Monday, with a temporary increase of over 10%. Since German Chancellor Olaf Scholz announced high investments in the German armed forces on February 27, 2022, the stock of the sensor and defense specialist shot up from EUR 12 to EUR 33. Since then, volatility has been high. Yesterday, the share price was around EUR 22. Before that, there had been a significant correction on Friday. The investor KKR significantly reduced its stake in Hensoldt. The Americans reduced their share from 17.8% to 8.3%. After the price increase not surprising and a sign that the share may have run a little hot. But the long-term potential is great. Not only in Germany. Yesterday, the French President also reiterated that France and the entire EU must invest in defense. And Hensoldt, with its state-of-the-art products, should not only profit from this. Last week, the "Welt am Sonntag" reported that the USA is interested in the passive radar developed by Hensoldt. However, the market capitalization is now a proud EUR 2.35 billion, and the P/E ratio is well into double digits. No mean feat, even if analysts' estimates for the coming years are likely to have some room for improvement in the meantime.

    Renewable energies, medical technology and defense are sectors with future potential. In the case of Perimeter, investors are counting on the successful product launch and will certainly need some patience. Hensoldt is currently clearly in the focus of investors but is no longer a bargain. At Nel, the mood of optimism is being weighed down by insider sales.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author

    Related comments:

    Commented by André Will-Laudien on June 2nd, 2023 | 08:30 CEST

    Is the Artificial intelligence hype already over? Nvidia, Star Navigation and with good chances of a correction!

    • AI
    • Innovations
    • Technology

    With an eye on rapid technological progress, the EU and the US want to cooperate more in the field of artificial intelligence (AI). "We are determined to make the most of the potential of emerging technologies while limiting the challenges they pose to universal human rights and shared democratic values," the Joint Trade and Technology Council announces. For the accompanying ethics committees, an important issue now comes to the table: what is a machine allowed to do, and what is it not allowed to do? So the current hype could be curbed again somewhat. Have AI values already peaked?


    Commented by Armin Schulz on June 1st, 2023 | 08:30 CEST

    Nel ASA, First Hydrogen, Plug Power - Paving the way for hydrogen technology

    • Hydrogen
    • greenhydrogen
    • GreenTech
    • renewableenergies

    Germany has shut down its nuclear power plants, and now the expansion of renewable energies is to be accelerated. But what happens to the surplus electricity when the sun shines all day? In order not to overload the grids, the energy is given away to neighbouring countries. In the future, it will be turned into green hydrogen that can cover the energy needs of industry and the transport sector. On May 25, the Federal Cabinet passed an amendment to the Energy Industry Act that defines the legal framework for a future hydrogen core network in Germany. Hydrogen technology will not only prevail in Germany. We, therefore, take a look at three international hydrogen companies.


    Commented by Nico Popp on May 30th, 2023 | 08:30 CEST

    Hydrogen drumbeat - where things can move quickly now: Plug Power, NEL, dynaCERT

    • Hydrogen
    • greenhydrogen
    • renewableenergies

    Green hydrogen is becoming a key technology for the industry in the fight against climate change. Wirtschaftswoche reports that by 2030, a whopping 13 million tons of hydrogen will be produced annually in Europe. But the necessary investments are still lacking. In the US, USD 10 billion have already been invested in hydrogen projects, while in Europe, only 7. In order for Europe to reach its goals, it must move faster. But this much already seems certain: companies in the hydrogen sector are facing an exciting phase - we take a closer look at three stocks.